Simply Better Brands Corp. (SBBC.V)

CAD 1.03

(1.98%)

EBITDA Summary of Simply Better Brands Corp.

  • Simply Better Brands Corp.'s latest annual EBITDA in 2023 was -18.22 Million USD , down -47.51% from previous year.
  • Simply Better Brands Corp.'s latest quarterly EBITDA in 2024 Q2 was -341.03 Thousand USD , down -139.33% from previous quarter.
  • Simply Better Brands Corp. reported an annual EBITDA of -4.53 Million USD in 2022, up 43.71% from previous year.
  • Simply Better Brands Corp. reported an annual EBITDA of -8.06 Million USD in 2021, down -638.68% from previous year.
  • Simply Better Brands Corp. reported a quarterly EBITDA of -341.03 Thousand USD for 2024 Q2, down -139.33% from previous quarter.
  • Simply Better Brands Corp. reported a quarterly EBITDA of N/A for 2023 FY, down -47.51% from previous quarter.

Annual EBITDA Chart of Simply Better Brands Corp. (2023 - 2019)

Historical Annual EBITDA of Simply Better Brands Corp. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -18.22 Million USD -47.51%
2022 -4.53 Million USD 43.71%
2021 -8.06 Million USD -638.68%
2020 1.49 Million USD -74.11%
2019 5.78 Million USD 0.0%

Peer EBITDA Comparison of Simply Better Brands Corp.

Name EBITDA EBITDA Difference
Aequus Pharmaceuticals Inc. -2.68 Million CAD -579.829%
CanadaBis Capital Inc. 5.67 Million CAD 421.048%
Decibel Cannabis Company Inc. 5.67 Million CAD 420.986%
Delivra Health Brands Inc. 2.35 Million CAD 874.375%
Entourage Health Corp. -21.39 Million CAD 14.806%
Lifeist Wellness Inc. -12.76 Million CAD -42.749%
Cannara Biotech Inc. 17.18 Million CAD 206.06%
Medicure Inc. 1.27 Million CAD 1531.955%
PharmaCielo Ltd. -12.01 Million CAD -51.671%
Rubicon Organics Inc. 1.94 Million CAD 1035.769%
BioSyent Inc. 9.05 Million CAD 301.254%
Voyageur Pharmaceuticals Ltd. -1.22 Million CAD -1392.997%